Cargando…
Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes”
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993848/ https://www.ncbi.nlm.nih.gov/pubmed/29785563 http://dx.doi.org/10.1007/s40265-018-0919-1 |
_version_ | 1783330298054836224 |
---|---|
author | Cohen, Hillel P. Blauvelt, Andrew Rifkin, Robert M. Danese, Silvio Gokhale, Sameer B. Woollett, Gillian |
author_facet | Cohen, Hillel P. Blauvelt, Andrew Rifkin, Robert M. Danese, Silvio Gokhale, Sameer B. Woollett, Gillian |
author_sort | Cohen, Hillel P. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5993848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-59938482018-06-21 Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” Cohen, Hillel P. Blauvelt, Andrew Rifkin, Robert M. Danese, Silvio Gokhale, Sameer B. Woollett, Gillian Drugs Letter to the Editor Springer International Publishing 2018-05-21 2018 /pmc/articles/PMC5993848/ /pubmed/29785563 http://dx.doi.org/10.1007/s40265-018-0919-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Letter to the Editor Cohen, Hillel P. Blauvelt, Andrew Rifkin, Robert M. Danese, Silvio Gokhale, Sameer B. Woollett, Gillian Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title | Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title_full | Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title_fullStr | Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title_full_unstemmed | Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title_short | Authors’ Reply to Pires et al.: “Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes” |
title_sort | authors’ reply to pires et al.: “switching reference medicines to biosimilars: a systematic literature review of clinical outcomes” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993848/ https://www.ncbi.nlm.nih.gov/pubmed/29785563 http://dx.doi.org/10.1007/s40265-018-0919-1 |
work_keys_str_mv | AT cohenhillelp authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes AT blauveltandrew authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes AT rifkinrobertm authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes AT danesesilvio authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes AT gokhalesameerb authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes AT woollettgillian authorsreplytopiresetalswitchingreferencemedicinestobiosimilarsasystematicliteraturereviewofclinicaloutcomes |